# Plain Language Summary: Advancing Safe Medications for Moms and Babies Act of 2022

Right now, pregnant and breastfeeding women are largely left out of medical research. When drug companies test new medications, they typically exclude pregnant women to avoid potential risks to the baby. The problem is that this leaves doctors with very little information about whether common medications are actually safe during pregnancy and breastfeeding. This bill aims to change that by making it easier and more encouraged for pregnant and lactating women to participate in clinical research studies.

The bill makes several practical changes to how medical research works. First, it updates federal regulations so that pregnant women are no longer automatically classified as a "vulnerable population" that needs extra restrictions on research participation. This removes a major legal barrier that has discouraged researchers from including them in studies. Second, the bill creates a national online clearinghouse—basically a searchable database—where pregnant and breastfeeding women, their families, and doctors can find information about clinical trials and research registries that are actively enrolling pregnant participants. This website will be user-friendly and updated regularly so people can easily find opportunities to participate.

The bill also establishes a coordinating committee made up of federal health officials, medical experts, nonprofit organizations, and industry representatives who will work together to identify gaps in medication research for pregnant and lactating women and recommend priorities for future studies. Additionally, the government will launch an education campaign to help the public understand why including pregnant women in research matters and to encourage participation. Finally, the National Institutes of Health will fund priority research projects specifically focused on studying medications that pregnant and breastfeeding women commonly use. The goal throughout is straightforward: gather better safety and effectiveness data on medications so doctors can make more informed decisions when treating pregnant patients.

Advancing Safe Medications for Moms and Babies Act of 2022

Castor, Kathy

Advancing Safe Medications for Moms and Babies Act of 2022 This bill establishes programs and requirements to support the inclusion of pregnant and lactating women in clinical research. For example, the bill requires the Department of Health and Human Services to align the Food and Drug Administration's regulations for human subjects in clinical trials with other departmental regulations for pregnant women in clinical research. The bill also establishes (1) a national online clearinghouse with information about clinical trials that enroll pregnant and lactating women, (2) an advisory committee to help coordinate federal activities with respect to clinical research for pregnant and lactating women, and (3) an educational campaign on the importance of including pregnant and lactating women in clinical research. The National Institutes of Health must also prioritize certain research projects on new and existing medications for pregnant and lactating women based on need, feasibility, and the potential impact of the research.